Mayank Dalakoti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mayank Dalakoti has a total of 435 co-authors. Here are the top co-authors by number of shared publications:
Roger Foo
Cardiovascular Metabolic Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore , 14 Medical Dr, 117599
5 shared publications- Fathima Aaysha Cader
Kettering General Hospital
4 shared publications - Roger Sik Yin Foo
Cardiovascular Research Institute, National University Health System
4 shared publications Tee Joo Yeo
Department of Cardiology, National University Heart Centre, Singapore
4 shared publicationsChing-Hui Sia
Department of Cardiology, National University Heart Centre, Singapore; Yong Loo Lin School of Medicine, National University of Singapore, Singapore
3 shared publications- Derek Pok Him Lee
Queen Elizabeth Hospital
3 shared publications
Latest Publications
- 8 September 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (12) , 2097-2099
Every step you take, every muscle you make: longer life for you
- 8 September 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (12) , 2097-2099
Every step you take, every muscle you make: longer life for you
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
- Vol. 19 (9)
PREVENT in Contemporary Practice: From External Validation to CKM Prevention
- 1 September 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
- Vol. 19 (9)
PREVENT in Contemporary Practice: From External Validation to CKM Prevention
- 1 August 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (11) , 1910-1912
Preventing cardiovascular disease in Africa: complexity, community, and the case for local solutions
- 1 August 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (11) , 1910-1912
Preventing cardiovascular disease in Africa: complexity, community, and the case for local solutions
- Open Access
- 30 July 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Preventing cardiovascular disease within the built and living environment: An Expert Opinion
Cardiovascular (CV) health is influenced not only by biological factors but also by the environments in which people live. The environment comprises interconnected built, living, and social domains that shape health behaviours, psychosocial well-being, environmental exposures, and access to resources. Within this framework, the built environment, the human-made settings that structure daily life, plays a key role in influencing physical activity, dietary behaviours, social interactions, safety, and overall well-being. Neighbourhoods are embedded within historical, legal, political, cultural, and economic contexts that shape the social determinants of health and contribute to CV health. Growing evidence indicates that characteristics of the living environment substantially influence cardiovascular disease (CVD) and related disorders, through multiple pathways. These include access to healthcare, air and noise pollution, availability of healthy foods and green spaces, physical activity, social cohesion, and chronic psychosocial stress. Potential mechanisms include inflammation, oxidative stress, neuroendocrine dysregulation, unhealthy lifestyle behaviours, and persistent stress responses that promote cardiometabolic dysfunction and vascular disease. This expert opinion examines challenges and opportunities related to nutrition, physical activity, environmental quality, community engagement, and occupational as well as social dimensions of the living environment from a public health perspective. This document highlights the importance of designing healthier communities that support CV health and reduce disease burden. Furthermore, neighbourhoods may serve as measurable units for monitoring CVD and broader health outcomes by integrating environmental characteristics with CV metrics, electronic health records, geospatial data, and neighbourhood-level social risk indicators. Addressing environmental determinants across multiple scales supports targeted public health strategies in Europe and globally.
- 30 July 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Open AccessPreventing cardiovascular disease within the built and living environment: An Expert Opinion
Cardiovascular (CV) health is influenced not only by biological factors but also by the environments in which people live. The environment comprises interconnected built, living, and social domains that shape health behaviours, psychosocial well-being, environmental exposures, and access to resources. Within this framework, the built environment, the human-made settings that structure daily life, plays a key role in influencing physical activity, dietary behaviours, social interactions, safety, and overall well-being. Neighbourhoods are embedded within historical, legal, political, cultural, and economic contexts that shape the social determinants of health and contribute to CV health. Growing evidence indicates that characteristics of the living environment substantially influence cardiovascular disease (CVD) and related disorders, through multiple pathways. These include access to healthcare, air and noise pollution, availability of healthy foods and green spaces, physical activity, social cohesion, and chronic psychosocial stress. Potential mechanisms include inflammation, oxidative stress, neuroendocrine dysregulation, unhealthy lifestyle behaviours, and persistent stress responses that promote cardiometabolic dysfunction and vascular disease. This expert opinion examines challenges and opportunities related to nutrition, physical activity, environmental quality, community engagement, and occupational as well as social dimensions of the living environment from a public health perspective. This document highlights the importance of designing healthier communities that support CV health and reduce disease burden. Furthermore, neighbourhoods may serve as measurable units for monitoring CVD and broader health outcomes by integrating environmental characteristics with CV metrics, electronic health records, geospatial data, and neighbourhood-level social risk indicators. Addressing environmental determinants across multiple scales supports targeted public health strategies in Europe and globally.
- Open Access
- 24 July 2026
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 39
Protocol for a Structured, Health Policy and Systems–Oriented Scoping Review of Determinants of Single-Pill Combination Availability in Sub-Saharan Africa
Background: Although international guidelines recommend single-pill combinations (SPCs) as first-line therapy for hypertension, their availability and use remain limited. Evidence on access to essential medicines is largely not specific to SPCs, and the determinants influencing their availability are dispersed across heterogeneous sources that are not well captured by traditional systematic review approaches. Objective: To describe the protocol for a structured, health policy and systems–oriented scoping review designed to map and synthesize the determinants of availability of antihypertensive SPCs in [...] Abstract Background: Although international guidelines recommend single-pill combinations (SPCs) as first-line therapy for hypertension, their availability and use remain limited. Evidence on access to essential medicines is largely not specific to SPCs, and the determinants influencing their availability are dispersed across heterogeneous sources that are not well captured by traditional systematic review approaches. Objective: To describe the protocol for a structured, health policy and systems–oriented scoping review designed to map and synthesize the determinants of availability of antihypertensive SPCs in
- 24 July 2026
- Published by Sociedade Brasileira de Cardiologia in International Journal of Cardiovascular Sciences
- Vol. 39
Open AccessProtocol for a Structured, Health Policy and Systems–Oriented Scoping Review of Determinants of Single-Pill Combination Availability in Sub-Saharan Africa
Background: Although international guidelines recommend single-pill combinations (SPCs) as first-line therapy for hypertension, their availability and use remain limited. Evidence on access to essential medicines is largely not specific to SPCs, and the determinants influencing their availability are dispersed across heterogeneous sources that are not well captured by traditional systematic review approaches. Objective: To describe the protocol for a structured, health policy and systems–oriented scoping review designed to map and synthesize the determinants of availability of antihypertensive SPCs in [...] Abstract Background: Although international guidelines recommend single-pill combinations (SPCs) as first-line therapy for hypertension, their availability and use remain limited. Evidence on access to essential medicines is largely not specific to SPCs, and the determinants influencing their availability are dispersed across heterogeneous sources that are not well captured by traditional systematic review approaches. Objective: To describe the protocol for a structured, health policy and systems–oriented scoping review designed to map and synthesize the determinants of availability of antihypertensive SPCs in
- 29 April 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (16) , 2963-2965
Primordial prevention of cardiovascular disease: from mirage to mission
- 29 April 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 33 (16) , 2963-2965
Primordial prevention of cardiovascular disease: from mirage to mission
- Open Access
- 27 April 2026
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
Management of Stable Coronary Artery Disease in the Asia-Pacific Region: Perspectives Among Different Cardiovascular Subspecialities
Limited data exist regarding subspeciality variation in the management of stable coronary artery disease within cardiology. In this multinational cross-sectional survey of 618 cardiologists across Asia-Pacific countries, including 233 interventional cardiologists (ICs), we analysed differences in knowledge, attitude and practices of ICs versus non-ICs using Wilcoxon signed-rank tests. Predictors of revascularisation were assessed via logistic regression. Although ICs had better knowledge of the guidelines than non-ICs, they exhibited poorer perception of treatment for stable coronary artery disease. Despite guideline recommendations for medical therapy, ICs were more likely to choose revascularisation across all case scenarios. Interventional subspeciality was the only significant predictor of preferentially choosing revascularisation. Future efforts can be focused on bridging the discrepancy between guidelines and practice.
- 27 April 2026
- Published by Radcliffe Medical Media Ltd in Journal of Asian Pacific Society of Cardiology
Open AccessManagement of Stable Coronary Artery Disease in the Asia-Pacific Region: Perspectives Among Different Cardiovascular Subspecialities
Limited data exist regarding subspeciality variation in the management of stable coronary artery disease within cardiology. In this multinational cross-sectional survey of 618 cardiologists across Asia-Pacific countries, including 233 interventional cardiologists (ICs), we analysed differences in knowledge, attitude and practices of ICs versus non-ICs using Wilcoxon signed-rank tests. Predictors of revascularisation were assessed via logistic regression. Although ICs had better knowledge of the guidelines than non-ICs, they exhibited poorer perception of treatment for stable coronary artery disease. Despite guideline recommendations for medical therapy, ICs were more likely to choose revascularisation across all case scenarios. Interventional subspeciality was the only significant predictor of preferentially choosing revascularisation. Future efforts can be focused on bridging the discrepancy between guidelines and practice.
- Top Cited PapersOpen Access
- 6 March 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Senescence-related myocardial dysfunction: keeping a young heart
The heart, a vital organ, works without interruption and constantly adjusts to the ever-changing demands on our body. It adapts to physiological and pathological changes, including exercise and emotional state, as well as metabolic, respiratory, and vascular abnormalities. The pumping action of the heart is determined by the health of the myocardium, which undergoes changes with ageing that are both under-investigated and incompletely understood, potentially impacting our approach to pathological conditions. Here, the alterations in cellular, tissue, and gross physiological function of the heart with age are discussed. At the molecular level, non-coding RNAs influence cellular senescence, and extracellular vesicles induce fibrosis through matrix remodelling. Mitochondrial dysfunction and altered fatty acid oxidation reduce cellular energetics, whilst accumulation of reactive oxygen species and steatosis, as well as telomere shortening coupled with reduced autophagy, limit the myocardium’s regenerative capability. Loss of cardiomyocytes, combined with senescence, requires compensatory hypertrophy, inducing myocardial stiffness and altered muscle function. In addition to these direct alterations in myocardial characteristics with ageing, other factors that can affect the myocardium indirectly are addressed, including valve calcification, resulting in regurgitation and/or stenosis; vascular abnormalities, reducing compliance and exacerbating hypertension; fibrosis leading to cardiac arrhythmias; and autonomic dysregulation, reducing cardiac adaptability. Finally, potential modulation of cardiac ageing is discussed whilst also addressing which senescent modifications should be considered as ageing-related physiological changes of the myocardium. A better understanding of myocardial ageing will differentiate physiological changes from early, preventable, and reversible pathological changes, consequently helping to optimize management of individuals with or at risk of myocardial disease by taking into account diverse trajectories of myocardial ageing.
- 6 March 2026
- Published by Oxford University Press (OUP) in European Heart Journal
Top Cited PapersOpen AccessSenescence-related myocardial dysfunction: keeping a young heart
The heart, a vital organ, works without interruption and constantly adjusts to the ever-changing demands on our body. It adapts to physiological and pathological changes, including exercise and emotional state, as well as metabolic, respiratory, and vascular abnormalities. The pumping action of the heart is determined by the health of the myocardium, which undergoes changes with ageing that are both under-investigated and incompletely understood, potentially impacting our approach to pathological conditions. Here, the alterations in cellular, tissue, and gross physiological function of the heart with age are discussed. At the molecular level, non-coding RNAs influence cellular senescence, and extracellular vesicles induce fibrosis through matrix remodelling. Mitochondrial dysfunction and altered fatty acid oxidation reduce cellular energetics, whilst accumulation of reactive oxygen species and steatosis, as well as telomere shortening coupled with reduced autophagy, limit the myocardium’s regenerative capability. Loss of cardiomyocytes, combined with senescence, requires compensatory hypertrophy, inducing myocardial stiffness and altered muscle function. In addition to these direct alterations in myocardial characteristics with ageing, other factors that can affect the myocardium indirectly are addressed, including valve calcification, resulting in regurgitation and/or stenosis; vascular abnormalities, reducing compliance and exacerbating hypertension; fibrosis leading to cardiac arrhythmias; and autonomic dysregulation, reducing cardiac adaptability. Finally, potential modulation of cardiac ageing is discussed whilst also addressing which senescent modifications should be considered as ageing-related physiological changes of the myocardium. A better understanding of myocardial ageing will differentiate physiological changes from early, preventable, and reversible pathological changes, consequently helping to optimize management of individuals with or at risk of myocardial disease by taking into account diverse trajectories of myocardial ageing.
- Open Access
- 18 February 2026
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (1) , 159-164
Cardiovascular risk in MASLD: What multiple lines of evidence reveal
- 18 February 2026
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (1) , 159-164
Open AccessCardiovascular risk in MASLD: What multiple lines of evidence reveal
- Open Access
- 13 January 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
The role of physical activity in an obesogenic environment for cardiovascular risk reduction across the lifespan: A Scientific Statement of the European Association of Preventive Cardiology of the ESC
The rising prevalence of obesity poses an increasing burden on individuals, health care systems, and society. Obesity is the main risk factor for several cardiovascular diseases (CVD). Physical activity (PA) may help to reduce the risk for CVD across the lifespan independent of obesity. The obesogenic and built environment can influence obesity and PA. The primary objective of this scientific statement is to underscore the role of obesity as a risk factor for CVD and to explore how PA can be leveraged to mitigate CVD risk. A novel aspect is the examination of how environmental factors influence the feasibility and implementation of current PA guidelines. Rather than focusing exclusively on a specific age group, this scientific statement investigates how environmental determinants may affect the implementation of increasing PA throughout the lifespan by focusing on three age groups: children and adolescents (<18 years), adults (18–64 years), and older adults (≥65 years). Furthermore, this scientific statement analyses the association of the built environment on PA behaviour by conducting a scoping literature review to identify age-specific evidence regarding the relation of the built environment on PA across the lifespan. This review highlights potentially effective strategies to reduce CVD risk within the context of the built environment and provides practical implications for healthcare professionals and policymakers to increase PA behaviour on an individual and societal level. Altogether, the present work raises awareness of the broader challenges posed by obesity and advocates for PA as a key strategy to improve public health outcomes.
- 13 January 2026
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Open AccessThe role of physical activity in an obesogenic environment for cardiovascular risk reduction across the lifespan: A Scientific Statement of the European Association of Preventive Cardiology of the ESC
The rising prevalence of obesity poses an increasing burden on individuals, health care systems, and society. Obesity is the main risk factor for several cardiovascular diseases (CVD). Physical activity (PA) may help to reduce the risk for CVD across the lifespan independent of obesity. The obesogenic and built environment can influence obesity and PA. The primary objective of this scientific statement is to underscore the role of obesity as a risk factor for CVD and to explore how PA can be leveraged to mitigate CVD risk. A novel aspect is the examination of how environmental factors influence the feasibility and implementation of current PA guidelines. Rather than focusing exclusively on a specific age group, this scientific statement investigates how environmental determinants may affect the implementation of increasing PA throughout the lifespan by focusing on three age groups: children and adolescents (<18 years), adults (18–64 years), and older adults (≥65 years). Furthermore, this scientific statement analyses the association of the built environment on PA behaviour by conducting a scoping literature review to identify age-specific evidence regarding the relation of the built environment on PA across the lifespan. This review highlights potentially effective strategies to reduce CVD risk within the context of the built environment and provides practical implications for healthcare professionals and policymakers to increase PA behaviour on an individual and societal level. Altogether, the present work raises awareness of the broader challenges posed by obesity and advocates for PA as a key strategy to improve public health outcomes.